Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Natural Killer Cell Therapy will have significant change from previous year. According to our latest study, the global Natural Killer Cell Therapy market size is USD million in 2022 from USD 250.2 million in 2021, with a change of % between 2021 and 2022. The global Natural Killer Cell Therapy market size will reach USD 1200.2 million in 2028, growing at a CAGR of 25.1% over the analysis period.
The United States Natural Killer Cell Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Natural Killer Cell Therapy market, reaching US$ million by the year 2028. As for the Europe Natural Killer Cell Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Natural Killer Cell Therapy players cover Nektar Therapeutics, Innate Pharma SA, Affimed, and Chipscreen Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
NK Cell Therapies
NK Cell Directed Antibodies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Gastrointestinal Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Natural Killer Cell Therapy Market Size 2017-2028
2.1.2 Natural Killer Cell Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Natural Killer Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy Market Size by Type
2.3.1 Natural Killer Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
2.4 Natural Killer Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 Natural Killer Cell Therapy Market Size by Application
2.5.1 Natural Killer Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Natural Killer Cell Therapy Market Size Market Share by Application (2017-2022)
3 Natural Killer Cell Therapy Market Size by Player
3.1 Natural Killer Cell Therapy Market Size Market Share by Players
3.1.1 Global Natural Killer Cell Therapy Revenue by Players (2020-2022)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Natural Killer Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Natural Killer Cell Therapy by Regions
4.1 Natural Killer Cell Therapy Market Size by Regions (2017-2022)
4.2 Americas Natural Killer Cell Therapy Market Size Growth (2017-2022)
4.3 APAC Natural Killer Cell Therapy Market Size Growth (2017-2022)
4.4 Europe Natural Killer Cell Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Natural Killer Cell Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Natural Killer Cell Therapy Market Size by Country (2017-2022)
5.2 Americas Natural Killer Cell Therapy Market Size by Type (2017-2022)
5.3 Americas Natural Killer Cell Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natural Killer Cell Therapy Market Size by Region (2017-2022)
6.2 APAC Natural Killer Cell Therapy Market Size by Type (2017-2022)
6.3 APAC Natural Killer Cell Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Natural Killer Cell Therapy by Country (2017-2022)
7.2 Europe Natural Killer Cell Therapy Market Size by Type (2017-2022)
7.3 Europe Natural Killer Cell Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Natural Killer Cell Therapy by Region (2017-2022)
8.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Natural Killer Cell Therapy Market Forecast
10.1 Global Natural Killer Cell Therapy Forecast by Regions (2023-2028)
10.1.1 Global Natural Killer Cell Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Natural Killer Cell Therapy Forecast
10.1.3 APAC Natural Killer Cell Therapy Forecast
10.1.4 Europe Natural Killer Cell Therapy Forecast
10.1.5 Middle East & Africa Natural Killer Cell Therapy Forecast
10.2 Americas Natural Killer Cell Therapy Forecast by Country (2023-2028)
10.2.1 United States Natural Killer Cell Therapy Market Forecast
10.2.2 Canada Natural Killer Cell Therapy Market Forecast
10.2.3 Mexico Natural Killer Cell Therapy Market Forecast
10.2.4 Brazil Natural Killer Cell Therapy Market Forecast
10.3 APAC Natural Killer Cell Therapy Forecast by Region (2023-2028)
10.3.1 China Natural Killer Cell Therapy Market Forecast
10.3.2 Japan Natural Killer Cell Therapy Market Forecast
10.3.3 Korea Natural Killer Cell Therapy Market Forecast
10.3.4 Southeast Asia Natural Killer Cell Therapy Market Forecast
10.3.5 India Natural Killer Cell Therapy Market Forecast
10.3.6 Australia Natural Killer Cell Therapy Market Forecast
10.4 Europe Natural Killer Cell Therapy Forecast by Country (2023-2028)
10.4.1 Germany Natural Killer Cell Therapy Market Forecast
10.4.2 France Natural Killer Cell Therapy Market Forecast
10.4.3 UK Natural Killer Cell Therapy Market Forecast
10.4.4 Italy Natural Killer Cell Therapy Market Forecast
10.4.5 Russia Natural Killer Cell Therapy Market Forecast
10.5 Middle East & Africa Natural Killer Cell Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Natural Killer Cell Therapy Market Forecast
10.5.2 South Africa Natural Killer Cell Therapy Market Forecast
10.5.3 Israel Natural Killer Cell Therapy Market Forecast
10.5.4 Turkey Natural Killer Cell Therapy Market Forecast
10.5.5 GCC Countries Natural Killer Cell Therapy Market Forecast
10.6 Global Natural Killer Cell Therapy Forecast by Type (2023-2028)
10.7 Global Natural Killer Cell Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Information
11.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Offered
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Nektar Therapeutics Main Business Overview
11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Information
11.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Offered
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Innate Pharma SA Main Business Overview
11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
11.3.1 Affimed Company Information
11.3.2 Affimed Natural Killer Cell Therapy Product Offered
11.3.3 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Affimed Main Business Overview
11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Information
11.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Chipscreen Biosciences Main Business Overview
11.4.5 Chipscreen Biosciences Latest Developments
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Information
11.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Glycostem Therapeutics Main Business Overview
11.5.5 Glycostem Therapeutics Latest Developments
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Information
11.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Offered
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fate Therapeutics Main Business Overview
11.6.5 Fate Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Information
11.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Dragonfly Therapeutics Main Business Overview
11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Information
11.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Offered
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Kiadis Pharma Main Business Overview
11.8.5 Kiadis Pharma Latest Developments
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Information
11.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Nkarta Therapeutics Main Business Overview
11.9.5 Nkarta Therapeutics Latest Developments
11.10 NantKwest
11.10.1 NantKwest Company Information
11.10.2 NantKwest Natural Killer Cell Therapy Product Offered
11.10.3 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 NantKwest Main Business Overview
11.10.5 NantKwest Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Natural Killer Cell Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of NK Cell Therapies
Table 3. Major Players of NK Cell Directed Antibodies
Table 4. Natural Killer Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Natural Killer Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
Table 7. Natural Killer Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Natural Killer Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Natural Killer Cell Therapy Market Size Market Share by Application (2017-2022)
Table 10. Global Natural Killer Cell Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Natural Killer Cell Therapy Revenue Market Share by Player (2020-2022)
Table 12. Natural Killer Cell Therapy Key Players Head office and Products Offered
Table 13. Natural Killer Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Natural Killer Cell Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Natural Killer Cell Therapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Natural Killer Cell Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Natural Killer Cell Therapy Market Size Market Share by Country (2017-2022)
Table 20. Americas Natural Killer Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
Table 22. Americas Natural Killer Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Natural Killer Cell Therapy Market Size Market Share by Application (2017-2022)
Table 24. APAC Natural Killer Cell Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Natural Killer Cell Therapy Market Size Market Share by Region (2017-2022)
Table 26. APAC Natural Killer Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
Table 28. APAC Natural Killer Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Natural Killer Cell Therapy Market Size Market Share by Application (2017-2022)
Table 30. Europe Natural Killer Cell Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Natural Killer Cell Therapy Market Size Market Share by Country (2017-2022)
Table 32. Europe Natural Killer Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
Table 34. Europe Natural Killer Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Natural Killer Cell Therapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Natural Killer Cell Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Natural Killer Cell Therapy
Table 43. Key Market Challenges & Risks of Natural Killer Cell Therapy
Table 44. Key Industry Trends of Natural Killer Cell Therapy
Table 45. Global Natural Killer Cell Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Natural Killer Cell Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Natural Killer Cell Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Nektar Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 52. Nektar Therapeutics Natural Killer Cell Therapy Product Offered
Table 53. Nektar Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Nektar Therapeutics Main Business
Table 55. Nektar Therapeutics Latest Developments
Table 56. Innate Pharma SA Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 57. Innate Pharma SA Natural Killer Cell Therapy Product Offered
Table 58. Innate Pharma SA Main Business
Table 59. Innate Pharma SA Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Innate Pharma SA Latest Developments
Table 61. Affimed Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 62. Affimed Natural Killer Cell Therapy Product Offered
Table 63. Affimed Main Business
Table 64. Affimed Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Affimed Latest Developments
Table 66. Chipscreen Biosciences Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 67. Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
Table 68. Chipscreen Biosciences Main Business
Table 69. Chipscreen Biosciences Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Chipscreen Biosciences Latest Developments
Table 71. Glycostem Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 72. Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
Table 73. Glycostem Therapeutics Main Business
Table 74. Glycostem Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Glycostem Therapeutics Latest Developments
Table 76. Fate Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 77. Fate Therapeutics Natural Killer Cell Therapy Product Offered
Table 78. Fate Therapeutics Main Business
Table 79. Fate Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Fate Therapeutics Latest Developments
Table 81. Dragonfly Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 82. Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
Table 83. Dragonfly Therapeutics Main Business
Table 84. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Dragonfly Therapeutics Latest Developments
Table 86. Kiadis Pharma Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 87. Kiadis Pharma Natural Killer Cell Therapy Product Offered
Table 88. Kiadis Pharma Main Business
Table 89. Kiadis Pharma Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Kiadis Pharma Latest Developments
Table 91. Nkarta Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 92. Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
Table 93. Nkarta Therapeutics Main Business
Table 94. Nkarta Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Nkarta Therapeutics Latest Developments
Table 96. NantKwest Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 97. NantKwest Natural Killer Cell Therapy Product Offered
Table 98. NantKwest Main Business
Table 99. NantKwest Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. NantKwest Latest Developments
List of Figures
Figure 1. Natural Killer Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer Cell Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Natural Killer Cell Therapy Market Size Market Share by Type in 2021
Figure 7. Natural Killer Cell Therapy in Cancer
Figure 8. Global Natural Killer Cell Therapy Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Natural Killer Cell Therapy in Gastrointestinal Diseases
Figure 10. Global Natural Killer Cell Therapy Market: Gastrointestinal Diseases (2017-2022) & ($ Millions)
Figure 11. Natural Killer Cell Therapy in Others
Figure 12. Global Natural Killer Cell Therapy Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Natural Killer Cell Therapy Market Size Market Share by Application in 2021
Figure 14. Global Natural Killer Cell Therapy Revenue Market Share by Player in 2021
Figure 15. Global Natural Killer Cell Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Natural Killer Cell Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Natural Killer Cell Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Natural Killer Cell Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Natural Killer Cell Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Natural Killer Cell Therapy Value Market Share by Country in 2021
Figure 21. Americas Natural Killer Cell Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Natural Killer Cell Therapy Market Size Market Share by Application in 2021
Figure 23. United States Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Natural Killer Cell Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Natural Killer Cell Therapy Market Size Market Share by Application in 2021
Figure 29. China Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Natural Killer Cell Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Natural Killer Cell Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Natural Killer Cell Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Natural Killer Cell Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Natural Killer Cell Therapy Market Size 2023-2028 ($ Millions)
